18.19
price down icon0.27%   -0.024
 
loading
前日終値:
$18.21
開ける:
$18
24時間の取引高:
419.77K
Relative Volume:
0.12
時価総額:
$4.98B
収益:
$426.45M
当期純損益:
$197.67M
株価収益率:
22.18
EPS:
0.82
ネットキャッシュフロー:
$110.10M
1週間 パフォーマンス:
+1.74%
1か月 パフォーマンス:
-8.47%
6か月 パフォーマンス:
+5.89%
1年 パフォーマンス:
+57.23%
1日の値動き範囲:
Value
$18.00
$18.34
1週間の範囲:
Value
$17.35
$18.91
52週間の値動き範囲:
Value
$10.21
$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Name
名前
Adma Biologics Inc
Name
セクター
Healthcare (1174)
Name
電話
(201) 478-5552
Name
住所
C/O ADMA BIOLOGICS, INC., RAMSEY
Name
職員
685
Name
Twitter
@AdmaBiologics
Name
次回の収益日
2025-03-03
Name
最新のSEC提出書
Name
ADMA's Discussions on Twitter

ADMA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ADMA
Adma Biologics Inc
18.18 4.98B 426.45M 197.67M 110.10M 0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
446.28 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
523.47 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
323.18 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
561.17 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
240.30 28.51B 3.81B -644.79M -669.77M -6.24

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-07-19 再開されました Raymond James Strong Buy
2022-10-13 開始されました Mizuho Buy
2021-11-11 アップグレード Raymond James Outperform → Strong Buy
2021-11-09 開始されました Cantor Fitzgerald Overweight
2019-06-04 開始されました Jefferies Buy
2019-04-15 繰り返されました H.C. Wainwright Buy
2019-02-07 再開されました H.C. Wainwright Buy
2017-12-11 繰り返されました Maxim Group Buy
2017-11-14 アップグレード Raymond James Mkt Perform → Outperform
2017-01-23 アップグレード Maxim Group Hold → Buy
2016-08-01 ダウングレード Maxim Group Buy → Hold
2016-07-25 繰り返されました Maxim Group Buy
2015-05-13 繰り返されました Maxim Group Buy
2014-12-08 開始されました Oppenheimer Outperform
2014-12-01 繰り返されました Maxim Group Buy
すべてを表示

Adma Biologics Inc (ADMA) 最新ニュース

pulisher
Jun 18, 2025

(ADMA) On The My Stocks Page - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 16, 2025

ADMA Looks to Expand Asceniv's Label: Will This Boost Sales? - sharewise

Jun 16, 2025
pulisher
Jun 15, 2025

ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade) - Seeking Alpha

Jun 15, 2025
pulisher
Jun 13, 2025

ADMA Biologics Stock Soars Amid Biotech Growth Nasdaq Composite Gains - Kalkine Media

Jun 13, 2025
pulisher
Jun 13, 2025

The 8.3% return this week takes ADMA Biologics' (NASDAQ:ADMA) shareholders three-year gains to 964% - simplywall.st

Jun 13, 2025
pulisher
Jun 11, 2025

ADMA Biologics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – ADMA - ACCESS Newswire

Jun 11, 2025
pulisher
Jun 10, 2025

Adma Biologics director sells $213,100 in stock - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

Adma Biologics director sells $213,100 in stock By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 06, 2025

ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold? - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

When (ADMA) Moves Investors should Listen - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 05, 2025

adma biologics holds annual meeting, elects directors and approves proposals - Investing.com Australia

Jun 05, 2025
pulisher
Jun 04, 2025

adma biologics holds annual meeting, elects directors and approves proposals By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

ADMA Biologics Holds Annual Stockholders Meeting - TipRanks

Jun 04, 2025
pulisher
May 28, 2025

ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy? - sharewise

May 28, 2025
pulisher
May 28, 2025

ADMA Biologics Vs. Grifols: Which Plasma Therapy Stock Is The Better Buy? - Barchart.com

May 28, 2025
pulisher
May 26, 2025

Where are the Opportunities in (ADMA) - news.stocktradersdaily.com

May 26, 2025
pulisher
May 25, 2025

Cetera Investment Advisers Decreases Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

May 25, 2025
pulisher
May 23, 2025

Adma Biologics director sells $182,635 in common stock - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Adma Biologics director sells $182,635 in common stock By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 23, 2025

Bank of America Corp DE Has $13.14 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

May 23, 2025
pulisher
May 23, 2025

Exploring High Growth Tech Stocks In The US May 2025 - Yahoo

May 23, 2025
pulisher
May 22, 2025

Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - The Globe and Mail

May 22, 2025
pulisher
May 22, 2025

Are Options Traders Betting On A Big Move In ADMA Biologics Stock? - Barchart.com

May 22, 2025
pulisher
May 20, 2025

BNP Paribas Financial Markets Sells 674,016 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

May 20, 2025
pulisher
May 19, 2025

Ameriprise Financial Inc. Acquires 88,542 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

May 19, 2025
pulisher
May 18, 2025

These 5 Buy-Ranked Mid-Cap Stocks Are Flying High Year to Date - The Globe and Mail

May 18, 2025
pulisher
May 16, 2025

(ADMA) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 16, 2025
pulisher
May 13, 2025

FY2025 EPS Estimates for ADMA Biologics Decreased by Analyst - Defense World

May 13, 2025
pulisher
May 12, 2025

Amid Bumpy Biotech Trade, I'm Eyeing These Two Stocks - TheStreet Pro

May 12, 2025
pulisher
May 11, 2025

Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus

May 11, 2025
pulisher
May 11, 2025

ADMA Biologics (NASDAQ:ADMA) Rating Lowered to “Sell” at StockNews.com - Defense World

May 11, 2025
pulisher
May 09, 2025

PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates - The Globe and Mail

May 09, 2025
pulisher
May 09, 2025

Revenue Gains, Bold Guidance Lift ADMA Shares - FXEmpire

May 09, 2025
pulisher
May 09, 2025

Adma Biologics (ADMA) Misses Q1 Earnings and Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss (NASDAQ:ADMA) - Seeking Alpha

May 09, 2025
pulisher
May 09, 2025

ADMA Biologics Reports Strong Growth and Strategic Advances - TipRanks

May 09, 2025
pulisher
May 08, 2025

ADMA Biologics (ADMA) Receives Price Target Upgrade from Raymond - GuruFocus

May 08, 2025
pulisher
May 08, 2025

ADMA Biologics (ADMA) Receives Price Target Upgrade from Raymond James | ADMA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

ADMA's Q1 Earnings and Revenues Miss: Buy, Sell or Hold the Stock? - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits - MSN

May 08, 2025
pulisher
May 08, 2025

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings - Benzinga

May 08, 2025
pulisher
May 08, 2025

Adma Biologics price target raised to $32 from $25 at Raymond James - TipRanks

May 08, 2025
pulisher
May 08, 2025

Raymond James Increases Price Target for ADMA Biologics | ADMA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

ADMA Biologics Inc (ADMA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

ADMA Biologics Inc (ADMA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Initiatives Propel Future Outlook - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Adma Biologics: Q1 Earnings Snapshot - New Haven Register

May 08, 2025
pulisher
May 08, 2025

ADMA Biologics Reports Strong Q1 2025 Financial Growth - TipRanks

May 08, 2025
pulisher
May 07, 2025

ADMA Biologics Inc earnings missed by $0.01, revenue topped estimates - Investing.com Nigeria

May 07, 2025

Adma Biologics Inc (ADMA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Adma Biologics Inc (ADMA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Grossman Adam S
President and CEO
Jun 16 '25
Sale
20.81
21,000
437,010
2,043,850
ELMS STEVE
Director
Jun 13 '25
Option Exercise
3.43
332,680
1,140,763
420,010
ELMS STEVE
Director
Jun 16 '25
Sale
20.24
194,749
3,941,720
87,330
ELMS STEVE
Director
Jun 13 '25
Sale
20.82
137,931
2,871,723
282,079
ELMS STEVE
Director
Jun 12 '25
Sale
21.69
92,941
2,015,890
2,031,730
$20.58
price down icon 0.29%
$36.03
price up icon 0.01%
$20.82
price down icon 2.33%
$99.35
price down icon 0.84%
$107.07
price up icon 0.55%
biotechnology ONC
$241.09
price down icon 0.43%
大文字化:     |  ボリューム (24 時間):